Atlas Trials

To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox

Clinical trial NCT00141479 · COMPLETED

Trial details

NCT number
NCT00141479
Sponsor
Solvay Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder
Start date
2005-05-01
Primary completion
2006-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.